Nerventra
Country: European Union
Language: Polish
Source: EMA (European Medicines Agency)
Public Assessment Report
(PAR)
23-05-2014
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
laquinimod
Available from:
Teva Pharma GmbH
ATC code:
N07
INN (International Name):
laquinimod
Therapeutic area:
Stwardnienie rozsiane
Therapeutic indications:
Leczenie stwardnienia rozsianego.
Authorization status:
Odmówił
